This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at https://www.rt.com/news/518771-oravax-oral-covid-vaccine/

The article has changed 3 times. There is an RSS feed of changes available.

Version 0 Version 1
World’s 1st ORAL Covid-19 vaccine could soon begin human trials World’s 1st ORAL Covid-19 vaccine could soon begin human trials
(6 months later)
A coronavirus vaccine that can be swallowed like a pill and administered at home could begin clinical trials in the near future after its developers reported promising preliminary data.A coronavirus vaccine that can be swallowed like a pill and administered at home could begin clinical trials in the near future after its developers reported promising preliminary data.
The trailblazing drug, called Oravax, is being developed by Israeli-American Oramed Pharmaceuticals and India-based Premas Biotech. The two companies have teamed up to create Oravax Medical Inc., which hopes to combine Oramed’s oral delivery technology with Premas’ vaccine expertise to create a new method of inoculation against Covid-19. The trailblazing drug, called Oravax, is being developed by Israeli-American Oramed Pharmaceuticals and India-based Premas Biotech. The two companies have teamed up to create Oravax Medical Inc., which hopes to combine Oramed’s oral delivery technology with Premas’ vaccine expertise to create a new method of inoculation against Covid-19. 
A pilot study conducted on animals found that the oral vaccine helped produce antibodies that create immunity against the virus, the company claims. The promising results were achieved by administering a single Oravax capsule, potentially setting the drug apart from some of the other vaccines which require two doses.A pilot study conducted on animals found that the oral vaccine helped produce antibodies that create immunity against the virus, the company claims. The promising results were achieved by administering a single Oravax capsule, potentially setting the drug apart from some of the other vaccines which require two doses.
Prabuddha Kundu, co-founder of Premas Biotech, told Indian media that administering the vaccine would be “like taking a vitamin pill” and that “we are more than 100% sure that the technology works and is promising.” Results from the preliminary animal tests would soon be published in a scientific journal, he added.Prabuddha Kundu, co-founder of Premas Biotech, told Indian media that administering the vaccine would be “like taking a vitamin pill” and that “we are more than 100% sure that the technology works and is promising.” Results from the preliminary animal tests would soon be published in a scientific journal, he added.
Oramed CEO Nadav Kidron told the Jerusalem Post that the oral drug would eliminate logistical problems that have arisen from worldwide mass vaccination drives, and that the pill could even be taken by individuals from the comfort of their home.Oramed CEO Nadav Kidron told the Jerusalem Post that the oral drug would eliminate logistical problems that have arisen from worldwide mass vaccination drives, and that the pill could even be taken by individuals from the comfort of their home.
The drug can be moved at refrigerator temperature and even stored at room temperature, alleviating some of the issues with some traditional vaccines, which must be kept extremely cold before use. Kidron also claimed that orally administering the vaccine could result in fewer side effects. The drug can be moved at refrigerator temperature and even stored at room temperature, alleviating some of the issues with some traditional vaccines, which must be kept extremely cold before use. Kidron also claimed that orally administering the vaccine could result in fewer side effects. 
The capsules would become particularly useful if Covid-19 vaccines are eventually “recommended annually like the standard flu shot,” he said. The capsules would become particularly useful if Covid-19 vaccines are eventually “recommended annually like the standard flu shot,” he said. 
Oravax Medical is currently applying to conduct human trials in several countries, including the United States, Israel, Mexico, and Europe. Studies could begin as soon as July.Oravax Medical is currently applying to conduct human trials in several countries, including the United States, Israel, Mexico, and Europe. Studies could begin as soon as July.
Like this story? Share it with a friend!Like this story? Share it with a friend!
Dear readers and commenters,
We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system.
Sorry for the inconvenience, and looking forward to your future comments,
RT Team.